Phase 3 Hypercholesterolaemia Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
efficacy of LOw dose antihypertensive and lipid lowering pill combinations To improve stroke oUtcomeS (LOTUS)
HypercholesterolaemiaHypertensionTransient Ischaemic Attack+1 more
The George Institute for Global Health Australia400 enrolled14 locationsACTRN12624001279516
Recruiting
Phase 3
Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd.582 enrolled1 locationNCT05621070
Terminated
Phase 3
Evaluating the efficacy and adherence of administration of a PCSK9 inhibitor Alirocumab in Aboriginal participants with hypercholesterolaemia
Hypercholesterolaemia
South Australian Health and Medical Research Institute200 enrolled3 locationsACTRN12616000871448
Completed
Phase 3
Dose Response Study of a Complementary Medicine Formulation in Primary Hypercholesterolaemia
Primary Hypercholesterolaemia
Pathways40 enrolled1 locationACTRN12605000232639